Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Gastroenterology|December 12, 2022
In vitro models to study Clostridioides difficile infection: current systems and future advancesDuncan Ewin, William Davis Birch, Ines B Moura
Infection Control and Hospital Epidemiology|March 17, 2021
From the hospital toilet to the ward: A pilot study on microbe dispersal to multiple hospital surfaces following hand drying using a jet air dryer versus paper towelsInes B Moura, Duncan Ewin, Mark H Wilcox
Antimicrobial Agents and Chemotherapy|November 21, 2018
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human ColonInes B Moura, Anthony M Buckley, Duncan Ewin, et al.
BMC Microbiology|January 4, 2020
Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colonInes B Moura, Charmaine Normington, Duncan Ewin, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut modelGrace S Crowther, Caroline H Chilton, Chris Longshaw, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut modelAnthony M Buckley, James Altringham, Emma Clark, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2021
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infectionAnthony M Buckley, Ines B Moura, James Altringham, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 7, 2018
Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgeryAndrew Kirby, Eduardo Asín-Prieto, Flora Agnes Burns, et al.
Jac-Antimicrobial Resistance|July 24, 2024
Antimicrobial susceptibility in <i>Clostridioides difficile</i> varies according to European region and isolate sourceJane Freeman, Virginie Viprey, Duncan Ewin, et al.
Pageof 2